139 related articles for article (PubMed ID: 30782264)
1. Association between
Sun L; Zhou M; Liu T
Pharmazie; 2019 Feb; 74(2):125-128. PubMed ID: 30782264
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of 17 β-hydroxysteroid dehydrogenase 3 and the risk of hypospadias.
Sata F; Kurahashi N; Ban S; Moriya K; Tanaka KD; Ishizuka M; Nakao H; Yahata Y; Imai H; Kakizaki H; Nonomura K; Kishi R
J Sex Med; 2010 Aug; 7(8):2729-38. PubMed ID: 20059664
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
4. Steroid 5-alpha-reductase type 2 (SRD5A2) gene V89L polymorphism and hypospadias risk: A meta-analysis.
Zhang K; Li Y; Mao Y; Ma M
J Pediatr Urol; 2017 Dec; 13(6):630.e1-630.e9. PubMed ID: 28713005
[TBL] [Abstract][Full Text] [Related]
5. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.
Rahimi M; Ghanbari M; Fazeli Z; Rouzrokh M; Omrani S; Mirfakhraie R; Omrani MD
J Endocrinol Invest; 2017 Apr; 40(4):391-396. PubMed ID: 27848231
[TBL] [Abstract][Full Text] [Related]
6. Hypospadias risk and polymorphism in SRD5A2 and CYP17 genes: case-control study among Indian children.
Samtani R; Bajpai M; Vashisht K; Ghosh PK; Saraswathy KN
J Urol; 2011 Jun; 185(6):2334-9. PubMed ID: 21511288
[TBL] [Abstract][Full Text] [Related]
7. The valine allele of the V89L polymorphism in the 5-alpha-reductase gene confers a reduced risk for hypospadias.
Thai HT; Kalbasi M; Lagerstedt K; Frisén L; Kockum I; Nordenskjöld A
J Clin Endocrinol Metab; 2005 Dec; 90(12):6695-8. PubMed ID: 16174723
[TBL] [Abstract][Full Text] [Related]
8. Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation?
van der Zanden LF; van Rooij IA; Feitz WF; Vermeulen SH; Kiemeney LA; Knoers NV; Roeleveld N; Franke B
J Clin Endocrinol Metab; 2010 May; 95(5):2384-90. PubMed ID: 20215396
[TBL] [Abstract][Full Text] [Related]
9. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
10. New insights into 5α-reductase type 2 deficiency based on a multi-centre study: regional distribution and genotype-phenotype profiling of
Gui B; Song Y; Su Z; Luo FH; Chen L; Wang X; Chen R; Yang Y; Wang J; Zhao X; Fan L; Liu X; Wang Y; Chen S; Gong C
J Med Genet; 2019 Oct; 56(10):685-692. PubMed ID: 31186340
[TBL] [Abstract][Full Text] [Related]
11. Single-nucleotide and copy-number variance related to severity of hypospadias.
Singh N; Gupta DK; Sharma S; Sahu DK; Mishra A; Yadav DK; Rawat J; Singh AK
Pediatr Surg Int; 2018 Sep; 34(9):991-1008. PubMed ID: 30078147
[TBL] [Abstract][Full Text] [Related]
12. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.
Choi SY; Kim HJ; Cheong HS; Myung SC
Korean J Urol; 2015 Jan; 56(1):19-30. PubMed ID: 25598933
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias.
Wang R; Dong Z; Wang W; Xiao Y; Ni J; Wang D
J Pediatr Endocrinol Metab; 2013; 26(9-10):887-93. PubMed ID: 23729601
[TBL] [Abstract][Full Text] [Related]
14. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
[No Abstract] [Full Text] [Related]
15. Expression of Xenobiotic Biomarkers CYP1 Family in Preputial Tissue of Patients with Hypospadias and Phimosis and Its Association with DNA Methylation Level of SRD5A2 Minimal Promoter.
Ohsako S; Aiba T; Miyado M; Fukami M; Ogata T; Hayashi Y; Mizuno K; Kojima Y
Arch Environ Contam Toxicol; 2018 Feb; 74(2):240-247. PubMed ID: 29080015
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype correlation and identification of two novel SRD5A2 mutations in 33 Chinese patients with hypospadias.
Yuan S; Meng L; Zhang Y; Tu C; Du J; Li W; Liang P; Lu G; Tan YQ
Steroids; 2017 Sep; 125():61-66. PubMed ID: 28663096
[TBL] [Abstract][Full Text] [Related]
17. Association of a tagging single nucleotide polymorphism in the androgen receptor gene region with susceptibility to severe hypospadias in a Caucasian population.
Adamovic T; Thai HT; Liedén A; Nordenskjöld A
Sex Dev; 2013; 7(4):173-9. PubMed ID: 23571770
[TBL] [Abstract][Full Text] [Related]
18. Relationship between SRD5A2 rs9282858 polymorphism and the susceptibility of prostate cancer: A meta-analysis based on 20 publications.
Fang C; Guo ZQ; Chen XY; Liu TZ; Zeng XT; Wang XH
Medicine (Baltimore); 2017 May; 96(19):e6791. PubMed ID: 28489754
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
20. Hypospadias and variants in genes related to sex hormone biosynthesis and metabolism.
Carmichael SL; Witte JS; Ma C; Lammer EJ; Shaw GM
Andrology; 2014 Jan; 2(1):130-7. PubMed ID: 24281767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
